GL1X · GenesisL1 explorer

UniProt Q9Y2Q9

28S ribosomal protein S28, mitochondrial (Q9Y2Q9)

28S ribosomal protein S28, mitochondrial (UniProt Q9Y2Q9): 13 experimental structures on GenesisL1, 2 ligands bound, 2 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q9Y2Q9
Protein
28S ribosomal protein S28, mitochondrial
Experimental structures
13
Predicted models
0
Ligands
2
Pockets
2 · 2 records with a druggable one

Structures

13 records of Q9Y2Q9 in the MolNFT archive: 13 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
3J9MStructure of the human mitochondrial ribosome (class 1)electron microscopyAW——
6NU2Structural insights into unique features of the human mitochondrial ribosome recyclingelectron microscopyAW——
6VLZStructure of the human mitochondrial ribosome-EF-G1 complex (ClassI)electron microscopyAW——
6ZS9Human mitochondrial ribosome in complex with ribosome recycling factorelectron microscopyAWZN—
6ZSBHuman mitochondrial ribosome in complex with mRNA and P-site tRNAelectron microscopyAW——
6ZSCHuman mitochondrial ribosome in complex with E-site tRNAelectron microscopyAWZN—
7QI6Human mitochondrial ribosome in complex with mRNA, A/P- and P/E-tRNAs at 2.98 A resolutionelectron microscopyAWMG—
8CSTHuman mitochondrial small subunit assembly intermediate (State E)electron microscopyWMG—
8CSUHuman mitochondrial small subunit assembly intermediate (State C*)electron microscopyWMG1 (best 0.77)
8K2ACryo-EM structure of the human 55S mitoribosome with Tigecyclineelectron microscopySd——
8OIR55S human mitochondrial ribosome with mtRF1 and P-site tRNAelectron microscopyAW——
8OIS28S human mitochondrial small ribosomal subunit with mtRF1 and P-site tRNAelectron microscopyAW—1 (best 0.81)
Q9Y2Q9AlphaFold monomer V2.0 prediction for 28S ribosomal protein S28, mitochondrial (Q9Y2Q9)———

Ligands

  • MG · Magnesium ion · in 3 records
  • ZN · Zinc ion · in 2 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.